Amgen Inc. (NASDAQ:AMGN) Q3 2024 Earnings Call Transcript
Operator: My name is Julianne, and I will be your conference facilitator today for Amgen's Third Quarter 2024 Financial Results Conference Call.
Amgen Inc (AMGN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 76,614 | $24,685,804 | +3% | 0.22% |
| 2. | Bourgeon Capital John Zaro | 54,046 | $17,414,050 | -1% | 3.34% |
| 3. | Levin Easterly Partners John Murphy | 51,948 | $16,738,165 | -7% | 1.34% |
| 4. | Bailard Inc Thomas Bailard | 46,725 | $15,055,263 | -1% | 0.39% |
| 5. | Lee Munder Capital Group Lee Munder | 37,147 | $11,969,134 | +1% | 0.71% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $165.50 | 10 | Director | 3,582 | 2015-08-19 | Filing | |
| $166.64 | 3,000 | Director | 3,572 | 2015-08-19 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $152.29 | 1,500 | Director | 2,000 | 2015-02-05 | Filing | |
| $111.77 | 894 | Officer, Director | 185,013 | 2014-05-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $313.09 | 2,117 | Officer | 9,883 | 2024-05-03 | Filing | |
| $273.03 | 2,096 | Officer | 10,874 | 2023-12-04 | Filing | |
| $272.81 | 10,000 | Officer | 28,078 | 2023-11-08 | Filing | |
| $262.43 | 9,558 | Officer | 44,308 | 2023-08-10 | Filing | |
| $292.90 | 387 | Officer | 6,630 | 2022-11-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 49,036,311 | $14,123,438,295 | 0.3% | |
| 2. | 47,812,390 | $13,770,924,367 | 0.35% | |
| 3. | 29,463,970 | $8,486,212,639 | 0.41% | |
| 4. | 14,591,468 | $4,202,634,613 | 3.32% | |
| 5. | 14,434,062 | $4,157,299,397 | 0.36% |
News See All
10 Buzzing AI Health Stocks
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively, by 2030, amounting ...
Amgen (AMGN) Rose Owing To The Announcement Of Promising Data For Its Novel Medication
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Healthcare Stocks To Buy According to Hedge Funds
Investing in healthcare equities is typically seen as protective during difficult economic times.
10 Undervalued Wide Moat Stocks to Buy According to Analysts
The US economy was able to pass its first soft-landing test by exhibiting resilience through the risky disinflation process. Market experts believe that inflation has now markedly cooled, enabling the...
Amgen Inc. (AMGN): A Bull Case Theory
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article we will summarize the bulls’ thesis on AMGN. AMGN Technologies, Inc.
10 Stocks That Will Change the World
If we were to try and summarize one of the biggest ways how to make money on the stock market, it'd include buying stocks of firms that have changed the world.
Amgen Inc. (NASDAQ:AMGN) Q2 2024 Earnings Call Transcript
Operator: My name is Julianne, and I will be your conference facilitator today for Amgen's Second Quarter 2024 Financial Results Conference Call.
The Most Advanced Country in Biomedical Engineering
The biotechnology global market size was estimated at $1.38 trillion in 2023 and is expected to reach around $4.25 trillion by 2033 while growing at a CAGR of 11.8%.
10 Best Blue Chip Dividend Stocks To Buy
When it comes to investing in stocks, investors often keep a close eye on the company's financial health. Why? Because it directly impacts the potential returns on their investments.